Cited by 2,116Autophagy in Disease and TherapyCancer-related Molecular PathwaysCell death mechanisms and regulation

Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor

Open access
Yue, Zhenyu, Jin, Shengkan, Yang, Chingwen, Levine, Arnold J., Heintz, Nathaniel·2003·Proceedings of the National Academy of Sciences

Abstract

The biochemical properties of beclin 1 suggest a role in two fundamentally important cell biological pathways: autophagy and apoptosis. We show here that beclin 1 -/- mutant mice die early in embryogenesis and beclin 1 +/- mutant mice suffer from a high incidence of spontaneous tumors. These tumors continue to express wild-type beclin 1 mRNA and protein, establishing that beclin 1 is a haploinsufficient tumor suppressor gene. Beclin 1 -/- embryonic stem cells have a severely altered autophagic response, whereas their apoptotic response to serum withdrawal or UV light is normal. These results demonstrate that beclin 1 is a critical component of mammalian autophagy and establish a role for autophagy in tumor suppression. They both provide a biological explanation for recent evidence implicating beclin 1 in human cancer and suggest that mutations in other genes operating in this pathway may contribute to tumor formation through deregulation of autophagy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.2436255100

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Becn1 haploinsufficient mice develop tumours, indicating autophagy might act as an important in vivo tumour suppressor.

    “In this case, the haploinsufficient mice developed tumours, indicating that autophagy might act as an important in vivo tumour suppressor 76, 77 .”

    From The common biology of cancer and ageing (2007) · cites this paper as [76]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 29

  1. [1]Klionsky, D. J. & Emr, S. D. (2000) Science 290, 1717-1721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. [2]Ohsumi, Y. (2001) Nat. Rev. Mol. Cell Biol. 2, 211-216. [DOI] [PubMed] [Google Scholar]
  3. [3]Khalfan, W. A. & Klionsky, D. J. (2002) Curr. Opin. Cell Biol. 14, 468-475. [DOI] [PubMed] [Google Scholar]
  4. [4]Bursch, W. (2001) Cell Death Differ. 8, 569-581. [DOI] [PubMed] [Google Scholar]
  5. [5]Xue, L., Fletcher, G. C. & Tolkovsky, A. M. (1999) Mol. Cell. Neurosci. 14, 180-198. [DOI] [PubMed] [Google Scholar]
  6. [6]Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H. & Levine, B. (1999) Nature 402, 672-676. [DOI] [PubMed] [Google Scholar]
  7. [7]Liang, X. H., Kleeman, L., Jiang, H., Gordon, G., Goldman, J., Berry, G., Herman, B. & Levine, B. (1998) J. Virol. 72, 8586-8596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. [8]Aita, V. M., Liang, X. H., Murty, V. V., Pincus, D. L., Yu, W., Cayanis, E., Kalachikov, S., Gilliam, T. C. & Levine, B. (1999) Genomics 59, 59-65. [DOI] [PubMed] [Google Scholar]
  9. [9]Yue, Z., Horton, A., Bravin, M., DeJager, P. L., Selimi, F. & Heintz, N. (2002) Neuron 35, 921-933. [DOI] [PubMed] [Google Scholar]
  10. [10]Manova, K., Tomihara-Newberger, C., Wang, S., Godelman, A., Kalantry, S., Witty-Blease, K., De Leon, V., Chen, W., Lacy, E. & Bachvarova, R. F. (1998) Dev. Dyn. 213, 293-308. [DOI] [PubMed] [Google Scholar]
  11. [11]Ilic, D., Almeida, E. A., Schlaepfer, D. D., Dazin, P., Aizawa, S. & Damsky, C. H. (1998) J. Cell Biol. 143, 547-560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. [12]Mizushima, N., Yamamoto, A., Hatano, M., Kobayashi, Y., Kabeya, Y., Suzuki, K., Tokuhisa, T., Ohsumi, Y. & Yoshimori, T. (2001) J. Cell Biol. 152, 657-668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. [13]Joza, N., Susin, S. A., Daugas, E., Stanford, W. L., Cho, S. K., Li, C. Y., Sasaki, T., Elia, A. J., Cheng, H. Y., Ravagnan, L., et al. (2001) Nature 410, 549-554. [DOI] [PubMed] [Google Scholar]
  14. [14]Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P. P. (1998) Nat. Genet. 19, 348-355. [DOI] [PubMed] [Google Scholar]
  15. [15]Kalantry, S., Manning, S., Haub, O., Tomihara-Newberger, C., Lee, H. G., Fangman, J., Disteche, C. M., Manova, K. & Lacy, E. (2001) Nat. Genet. 27, 412-416. [DOI] [PubMed] [Google Scholar]
  16. [16]Xu, D., Wilson, T. J., Chan, D., De Luca, E., Zhou, J., Hertzog, P. J. & Kola, I. (2002) EMBO J. 21, 4081-4093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. [17]Chao, C., Saito, S., Kang, J., Anderson, C. W., Appella, E. & Xu, Y. (2000) EMBO J. 19, 4967-4675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. [18]Schuler, M. & Green, D. R. (2001) Biochem. Soc. Trans. 29, 684-688. [DOI] [PubMed] [Google Scholar]
  19. [19]Rossant, J. & Cross, J. C. (2002) in Mouse Development, eds. Rossant, J. & Tam, P. R. L. (Academic, New York), pp. 155-180.
  20. [20]Kisen, G. O., Tessitore, L., Costelli, P., Gordon, P. B., Schwarze, P. E., Baccino, F. M. & Seglen, P. O. (1993) Carcinogenesis 14, 2501-2505. [DOI] [PubMed] [Google Scholar]
  21. [21]Cantley, L. C. & Neel, B. G. (1999) Proc. Natl. Acad. Sci. USA 96, 4240-4245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. [22]Testa, J. R. & Bellacosa, A. (2001) Proc. Natl. Acad. Sci. USA 98, 10983-10985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. [23]Lawlor, M. A. & Alessi, D. R. (2001) J. Cell Sci. 114, 2903-2910. [DOI] [PubMed] [Google Scholar]
  24. [24]Arico, S., Petiot, A., Bauvy, C., Dubbelhuis, P. F., Meijer, A. J., Codogno, P. & Ogier-Denis, E. (2001) J. Biol. Chem. 276, 35243-35246. [DOI] [PubMed] [Google Scholar]
  25. [25]Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K. L. (2002) Nat. Cell Biol. 4, 648-657. [DOI] [PubMed] [Google Scholar]
  26. [26]Fingar, D. C., Salama, S., Tsou, C., Harlow, E. & Blenis, J. (2002) Genes Dev. 16, 1472-1487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. [27]Weinmann, A. S., Bartley, S. M., Zhang, T., Zhang, M. Q. & Farnham, P. J. (2001) Mol. Cell. Biol. 21, 6820-6832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. [28]Nevins, J. R. (2001) Hum. Mol. Genet. 10, 699-703. [DOI] [PubMed] [Google Scholar]
  29. [29]Ogier-Denis, E. & Codogno, P. (2003) Biochim. Biophys. Acta 1603, 113-128. [DOI] [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Yue, Z., Jin, S., Yang, C., Levine, A. J., & Heintz, N.
Affiliations
Howard Hughes Medical Institute (US)
Venue
Proceedings of the National Academy of Sciences
Published
2003-12
Volume
100
Issue
25
Pages
15077-15082
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2066800765
Cited by
2,116
References
30
Citations by year
2026: 28 · 2025: 51 · 2024: 74 · 2023: 70 · 2022: 89 · 2021: 105 · 2020: 113 · 2019: 106 · 2018: 103 · 2017: 107 · 2016: 115 · 2015: 133 · 2014: 120 · 2013: 168 · 2012: 132
FWCI
25.54
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
Beclin-1, autophagy, haploinsufficiency, tumor suppressor, early embryonic development, embryonic lethality, spontaneous tumors, apoptosis, embryonic stem cells, UV-induced apoptosis, serum deprivation, cancer
MeSH terms
Beclin-1, Animals, Autophagy, Embryo, Mammalian, Membrane Proteins, Mice, Inbred C57BL, Mice, Mutant Strains, Mice, Transgenic, Microscopy, Electron, Models, Genetic, Mutation, Neoplasms, Proteins, RNA, Messenger, Time Factors, Ultraviolet Rays, Genes, Tumor Suppressor, Apoptosis, Gene Deletion, Apoptosis Regulatory Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review